OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
Active, not recruiting · NCT05949021 · Registry updated 2025-11-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 2 | 2025-11-14 | NCT05949021 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mridula George, MD | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rutgers Cancer Institute of New Jersey | New Brunswick | United States | 223 |
| RWJBarnabas Health - Community Medical Center | Toms River | United States | 9 |
| RWJBarnabas Health - Monmouth Medical Center Southern Campus | Lakewood | United States | 8 |
| RWJBarnabas Health - Newark Beth Israel Medical Center | Newark | United States | 7 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | New Brunswick | United States | 5 |
| RWJBarnabas Health - Trinitas hospital and Comprehensive Center | Elizabeth | United States | 1 |
| RWJBarnabas Health Jersey City Medical Center | Jersey City | United States | 4 |
| University Hospital-Newark | Newark | United States | 1 |